Terms: = Ovarian cancer AND BTG1, P62324, 694, ENSG00000133639 AND Diagnosis
11 results:
1. Prevalence and predictors for fertility-related distress among 1010 young adults 1.5 years following cancer diagnosis - results from the population-based Fex-Can Cohort study.
Rodriguez-Wallberg KA; Ahlgren J; Smedby KE; Gorman JR; Hellman K; Henriksson R; Ståhl O; Wettergren L; Lampic C
Acta Oncol; 2023 Dec; 62(12):1599-1606. PubMed ID: 37909865
[TBL] [Abstract] [Full Text] [Related]
2. Ultrasonographic diagnosis of adnexal masses: interobserver agreement in the interpretation of videos, using IOTA terminology.
Massobrio R; Mariani LL; Conti D; De Grandis T; Buonomo F; Badellino E; Novara L; Bounous VE; Perotto S; Mancarella M; Ferrero A; Biglia N; Fuso L
Arch Gynecol Obstet; 2024 Jan; 309(1):211-218. PubMed ID: 37789207
[TBL] [Abstract] [Full Text] [Related]
3. Combination of clinical and MRI features in diagnosing ovarian granulosa cell tumor: A comparison with other ovarian sex cord-gonadal stromal tumors.
Zhang J; Zhang Y; Guo Y
Eur J Radiol; 2023 Jan; 158():110593. PubMed ID: 36434968
[TBL] [Abstract] [Full Text] [Related]
4. circMAN1A2 could serve as a novel serum biomarker for malignant tumors.
Fan CM; Wang JP; Tang YY; Zhao J; He SY; Xiong F; Guo C; Xiang B; Zhou M; Li XL; Li Y; Li GY; Xiong W; Zeng ZY
Cancer Sci; 2019 Jul; 110(7):2180-2188. PubMed ID: 31046163
[TBL] [Abstract] [Full Text] [Related]
5. [The prophylactic operational model integrated with occupational healthcare - Prophylactic of some types of cancers among women].
Wiszniewska M; Magnuska J; Lipińska-Ojrzanowska A; Pepłońska B; Hanke W; Kalinka J; Skręt-Magierło J; Zadrożny M; Walusiak-Skorupa J
Med Pr; 2018 Aug; 69(4):439-455. PubMed ID: 30038434
[TBL] [Abstract] [Full Text] [Related]
6. Expression and prognosis analyses of the Tob/BTG antiproliferative (APRO) protein family in human cancers.
Bai Y; Qiao L; Xie N; Shi Y; Liu N; Wang J
PLoS One; 2017; 12(9):e0184902. PubMed ID: 28922388
[TBL] [Abstract] [Full Text] [Related]
7. Blood type, ABO genetic variants, and ovarian cancer survival.
Cozzi GD; Levinson RT; Toole H; Snyder MR; Deng A; Crispens MA; Khabele D; Beeghly-Fadiel A
PLoS One; 2017; 12(4):e0175119. PubMed ID: 28448592
[TBL] [Abstract] [Full Text] [Related]
8. The Establishment of an HE4-CLIA Method and the Combined Analysis of HE4 and CA125 in ovarian cancer.
Zhang Q; Wang CR; Yu JP; Ma Q; Xu WW
J Clin Lab Anal; 2016 Sep; 30(5):709-18. PubMed ID: 26990679
[TBL] [Abstract] [Full Text] [Related]
9. Prospective study of DNA methylation at LINE-1 and Alu in peripheral blood and the risk of prostate cancer.
Barry KH; Moore LE; Liao LM; Huang WY; Andreotti G; Poulin M; Berndt SI
Prostate; 2015 Nov; 75(15):1718-25. PubMed ID: 26250474
[TBL] [Abstract] [Full Text] [Related]
10. Evaluation of serum autoantibody levels in the diagnosis of ovarian endometrioma.
Yi YC; Wang SC; Chao CC; Su CL; Lee YL; Chen LY
J Clin Lab Anal; 2010; 24(5):357-62. PubMed ID: 20872572
[TBL] [Abstract] [Full Text] [Related]
11. Three-dimensional power Doppler vascular sampling: a new method for predicting ovarian cancer in vascularized complex adnexal masses.
Alcázar JL; Mercé LT; García Manero M
J Ultrasound Med; 2005 May; 24(5):689-96. PubMed ID: 15840800
[TBL] [Abstract] [Full Text] [Related]
